XENON PHARMACEUTICALS INC. (XENE) /

The profitability of XENON PHARMACEUTICALS INC. over the past 10 years

Chart XENON PHARMACEUTICALS INC.: operating income, net income, fiscal 2016–2025 Open the chart →

XENON PHARMACEUTICALS INC. reported a net loss of $345.91M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $373.07M. It reported a loss in all 10 years shown.

Year by year

Fiscal yearOperating incomeNet income
2025ended Dec 31, 2025-$373.07M-$345.91M
2024ended Dec 31, 2024-$279.3M-$234.33M
2023ended Dec 31, 2023-$214.05M-$182.39M
2022ended Dec 31, 2022-$129.14M-$125.37M
2021ended Dec 31, 2021-$78.99M-$78.88M
2020ended Dec 31, 2020-$31.3M-$28.84M
2019ended Dec 31, 2019-$42.82M-$41.59M
2018ended Dec 31, 2018-$38.04M-$34.5M
2017ended Dec 31, 2017-$32.58M-$30.7M
2016ended Dec 31, 2016-$24.82M-$23M

Fiscal years as XENON PHARMACEUTICALS INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on XENON PHARMACEUTICALS INC.

Companies of a similar size

Not investment advice. This page shows what XENON PHARMACEUTICALS INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.